THEMIS MEDICARE Financial Statement Analysis
|
||
|
The Revenues of THEMIS MEDICARE have increased by 6.22% YoY .
The Earnings Per Share (EPS) of THEMIS MEDICARE has decreased by -31.50 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
THEMIS MEDICARE Last 5 Annual Financial Results
[BOM: 530199|NSE : THEMISMED]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹406 Cr | ₹382 Cr | ₹354 Cr | ₹395 Cr | ₹231 Cr |
| Expenses | ₹356 Cr | ₹330 Cr | ₹287 Cr | ₹299 Cr | ₹181 Cr |
| Operating Profit (Excl OI) | ₹49 Cr | ₹52 Cr | ₹67 Cr | ₹96 Cr | ₹49 Cr |
| Other Income | ₹4.67 Cr | ₹4.76 Cr | ₹12 Cr | ₹6.54 Cr | ₹3.62 Cr |
| Interest | ₹10 Cr | ₹9.38 Cr | ₹9.56 Cr | ₹8.78 Cr | ₹13 Cr |
| Depreciation | ₹9.93 Cr | ₹12 Cr | ₹10 Cr | ₹9.48 Cr | ₹8.55 Cr |
| Profit Before Tax | ₹40 Cr | ₹53 Cr | ₹73 Cr | ₹95 Cr | ₹41 Cr |
| Profit After Tax | ₹30 Cr | ₹44 Cr | ₹57 Cr | ₹73 Cr | ₹36 Cr |
| Consolidated Net Profit | ₹30 Cr | ₹44 Cr | ₹57 Cr | ₹73 Cr | ₹36 Cr |
| Earnings Per Share (Rs) | ₹3.24 | ₹4.73 | ₹61.83 | ₹79.22 | ₹38.86 |
| PAT Margin (%) | 7.36 | 11.40 | 16.06 | 18.47 | 15.48 |
| ROE(%) | 7.65 | 12.14 | 18.16 | 28.84 | 17.82 |
| ROCE(%) | 10.37 | 13.89 | 20.59 | 31.07 | 18.44 |
| Total Debt/Equity(x) | 0.21 | 0.25 | 0.27 | 0.27 | 0.39 |
Key Financials |
||
| Market Cap | : | ₹ 1,179.0 Cr |
| Revenue (TTM) | : | ₹ 380.1 Cr |
| Net Profit(TTM) | : | ₹ -8.9 Cr |
| EPS (TTM) | : | ₹ -1.0 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| THEMIS MEDICARE | 1.4% | -10% | -53.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.2% | 3.6% | -7.8% |
| DIVIS LABORATORIES | -2.4% | 9.1% | 13.4% |
| CIPLA | -5.7% | 4% | 6.7% |
| TORRENT PHARMACEUTICALS | -0.3% | 1.3% | 8.3% |
| DR REDDYS LABORATORIES | 0.1% | 1.2% | -2.8% |
| MANKIND PHARMA | -1.7% | -4.6% | -4.5% |
| ZYDUS LIFESCIENCES | 0.2% | -1.7% | 1.3% |
| LUPIN | -1.1% | -2.1% | -7.3% |
THEMIS MEDICARE Revenues
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | 6.22 % |
| 5 Yr CAGR | 15.15 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹406 Cr | 6.22 | |
| Mar2024 | ₹382 Cr | 7.74 | |
| Mar2023 | ₹354 Cr | -10.21 | |
| Mar2022 | ₹395 Cr | 71.07 | |
| Mar2021 | ₹231 Cr | - | |
THEMIS MEDICARE Operating Profit
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | -4.77 % |
| 5 Yr CAGR | -0.23 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹49 Cr | -4.77 | |
| Mar2024 | ₹52 Cr | -23.64 | |
| Mar2023 | ₹67 Cr | -29.47 | |
| Mar2022 | ₹96 Cr | 93.23 | |
| Mar2021 | ₹49 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -10.30 % |
| 5 Yr CAGR | -13.35 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 12.1% | -10.30 | |
| Mar2024 | 13.49% | -29.15 | |
| Mar2023 | 19.04% | -21.45 | |
| Mar2022 | 24.24% | 12.95 | |
| Mar2021 | 21.46% | - | |
THEMIS MEDICARE Profit After Tax
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | -31.46 % |
| 5 Yr CAGR | -4.39 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | -31.46 | |
| Mar2024 | ₹44 Cr | -23.51 | |
| Mar2023 | ₹57 Cr | -21.93 | |
| Mar2022 | ₹73 Cr | 104.13 | |
| Mar2021 | ₹36 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -35.44 % |
| 5 Yr CAGR | -16.96 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 7.36 % | -35.44 | |
| Mar2024 | 11.4 % | -29.02 | |
| Mar2023 | 16.06 % | -13.05 | |
| Mar2022 | 18.47 % | 19.32 | |
| Mar2021 | 15.48 % | - | |
THEMIS MEDICARE Earnings Per Share (EPS)
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | -31.50 % |
| 5 Yr CAGR | -46.26 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.24 | -31.50 | |
| Mar2024 | ₹4.73 | -92.35 | |
| Mar2023 | ₹62 | -21.95 | |
| Mar2022 | ₹79 | 103.86 | |
| Mar2021 | ₹39 | - | |
THEMIS MEDICARE Return on Capital Employed (ROCE)
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | -25.34 % |
| 5 Yr CAGR | -13.40 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 10.37% | -25.34 | |
| Mar2024 | 13.89% | -32.54 | |
| Mar2023 | 20.59% | -33.73 | |
| Mar2022 | 31.07% | 68.49 | |
| Mar2021 | 18.44% | - | |
THEMIS MEDICARE Share Price vs Sensex
| Current Share Price | : | ₹128.2 |
| Current MarketCap | : | ₹ 1,179.0 Cr |
| Updated EOD on | : | Oct 28,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | 1.4% |
-10% |
-53.6% |
| SENSEX | 0.3% |
3.6% |
5.5% |
THEMIS MEDICARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | 0.9% | 0.1% | 0.5% |
| BSE HEALTHCARE | -1% | 1.2% | 4% |
No NSE index found
You may also like the below Video Courses
FAQ about THEMIS MEDICARE Financials
How the annual revenues of THEMIS MEDICARE have changed ?
The Revenues of THEMIS MEDICARE have increased by 6.22% YoY .
How the Earnings per Share (EPS) of THEMIS MEDICARE have changed?
The Earnings Per Share (EPS) of THEMIS MEDICARE has decreased by -31.50 % YoY .
Check out Intrinsic Value of Peers of THEMIS MEDICARE
Compare Stock Analytics of Peers of THEMIS MEDICARE
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
